Published in J Cell Mol Med on January 20, 2014
Cardiac Stem Cell Infusion in Patients With Ischemic CardiOmyopathy (SCIPIO) (SCIPIO) | NCT00474461
State of the Art on the Evidence Base in Cardiac Regenerative Therapy: Overview of 41 Systematic Reviews. Biomed Res Int (2015) 0.82
The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells. Biomed Res Int (2015) 0.79
Influence of Egr-1 in cardiac tissue-derived mesenchymal stem cells in response to glucose variations. Biomed Res Int (2014) 0.78
Patient-Specific Age: The Other Side of the Coin in Advanced Mesenchymal Stem Cell Therapy. Front Physiol (2015) 0.77
Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts. J Transl Med (2017) 0.75
Foetal bovine serum-derived exosomes affect yield and phenotype of human cardiac progenitor cell culture. Bioimpacts (2016) 0.75
Bridging the Gap between Translational and Outcome Research in Cardiovascular Disease. Biomed Res Int (2015) 0.75
Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells. Sci Rep (2016) 0.75
Multidisciplinary approaches to stimulate wound healing. Ann N Y Acad Sci (2016) 0.75
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (2012) 9.86
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol (2012) 3.48
Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol (2008) 2.70
Cardiac cell therapy: where we've been, where we are, and where we should be headed. Br Med Bull (2011) 2.26
Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells (2009) 2.19
Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol (2011) 2.15
Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair. Stem Cells (2010) 2.10
Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells (2007) 2.09
Neural stem cell engraftment and myelination in the human brain. Sci Transl Med (2012) 1.96
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica (2007) 1.82
Endogenous cardiac stem cells. Prog Cardiovasc Dis (2007) 1.79
Cardiac cell therapy: lessons from clinical trials. J Mol Cell Cardiol (2010) 1.59
High efficacy of clonal growth and expansion of adult neural stem cells. Lab Invest (2003) 1.47
N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells (2006) 1.43
GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One (2012) 1.33
The stuttering progress of cell therapy for heart disease. Clin Pharmacol Ther (2011) 1.20
"Humanized" stem cell culture techniques: the animal serum controversy. Stem Cells Int (2011) 1.18
Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture media. ALTEX (2011) 1.13
Identification of valid housekeeping genes for quantitative RT-PCR analysis of cardiosphere-derived cells preconditioned under hypoxia or with prolyl-4-hydroxylase inhibitors. Mol Biol Rep (2011) 1.10
Selective culture of mesodermal progenitor cells. Stem Cells Dev (2009) 1.06
Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements. Tissue Eng Part A (2010) 1.05
Cell therapy of acute myocardial infarction: open questions. Cardiology (2008) 1.04
Spermatogonial culture medium: an effective and efficient nutrient mixture for culturing rat spermatogonial stem cells. Biol Reprod (2009) 1.00
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J Cell Mol Med (2010) 1.00
Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J Neurosurg Pediatr (2013) 0.98
Human platelet lysate as a fetal bovine serum substitute improves human adipose-derived stromal cell culture for future cardiac repair applications. Cell Tissue Res (2012) 0.97
High yield of cells committed to the photoreceptor fate from expanded mouse retinal stem cells. Stem Cells (2006) 0.96
Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts. Methods Mol Biol (2012) 0.96
Isolation and characterization of human dental pulp derived stem cells by using media containing low human serum percentage as clinical grade substitutes for bovine serum. PLoS One (2012) 0.95
Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs. Biomaterials (2011) 0.94
Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy. Scand J Clin Lab Invest (2008) 0.93
Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev (2011) 0.91
Functional impairment of human resident cardiac stem cells by the cardiotoxic antineoplastic agent trastuzumab. Stem Cells Transl Med (2012) 0.89
Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum. Cytotherapy (2012) 0.89
TGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies. Stem Cells Dev (2012) 0.89
Animal serum-free expansion and differentiation of human mesenchymal stromal cells. Cytotherapy (2010) 0.89
Cardiac cell therapy: the next (re)generation. Stem Cell Rev (2011) 0.88
Caffeine-induced Ca(2+) signaling as an index of cardiac progenitor cells differentiation. Basic Res Cardiol (2010) 0.88
From ontogenesis to regeneration: learning how to instruct adult cardiac progenitor cells. Prog Mol Biol Transl Sci (2012) 0.87
Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: towards clinical studies in ischaemic disease. J Cardiovasc Transl Res (2012) 0.87
Thrombin and thrombin-derived peptides promote proliferation of cardiac progenitor cells in the form of cardiospheres without affecting their differentiation potential. J Biol Regul Homeost Agents (2011) 0.86
Effectiveness of autologous serum as an alternative to fetal bovine serum in adipose-derived stem cell engineering. Cell Tissue Bank (2012) 0.84
An effective and safe supplement for stem cells expansion ex vivo: cord blood serum. Cell Transplant (2011) 0.84
New perspectives to repair a broken heart. Cardiovasc Hematol Agents Med Chem (2009) 0.83
A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts. Cell Tissue Bank (2012) 0.83
Clinical grade cultivation of human Schwann cell, by the using of human autologous serum instead of fetal bovine serum and without growth factors. Cell Tissue Bank (2011) 0.81
Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate. Cell Prolif (2011) 0.80
BDNF and extracellular matrix regulate differentiation of mice neurosphere-derived cells into a GABAergic neuronal phenotype. J Neurosci Res (2009) 0.79
Sequential use of human-derived medium supplements favours cardiovascular tissue engineering. J Cell Mol Med (2012) 0.78
Impact of culture conditions on the proliferative lifespan of human T cells in vitro. Cytotherapy (2007) 0.78
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res (2010) 4.19
Does ministernotomy improve postoperative outcome in aortic valve operation? A prospective randomized study. Ann Thorac Surg (2002) 2.55
Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials. Eur Heart J Cardiovasc Imaging (2012) 2.19
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. Am Heart J (2013) 2.09
Histone deacetylase 7 controls endothelial cell growth through modulation of beta-catenin. Circ Res (2010) 1.87
Spontaneous pneumopericardium after coronary angioplasty. Tex Heart Inst J (2010) 1.87
Endogenous cardiac stem cells. Prog Cardiovasc Dis (2007) 1.79
A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc (2013) 1.77
Guanine nucleotide depletion triggers cell cycle arrest and apoptosis in human neuroblastoma cell lines. Int J Cancer (2004) 1.68
Coronary calcification identifies the vulnerable patient rather than the vulnerable Plaque. Atherosclerosis (2013) 1.66
Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting. J Vasc Surg (2011) 1.66
Differentiation of human adult cardiac stem cells exposed to extremely low-frequency electromagnetic fields. Cardiovasc Res (2009) 1.65
Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes (2002) 1.65
Postoperative outcome in patients with accessory mitral valve tissue. Med Sci Monit (2003) 1.63
Atherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: a meta-regression of randomized clinical trials. Atherosclerosis (2012) 1.63
Cooperation between insulin and leptin in the modulation of vascular tone. Hypertension (2003) 1.60
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction. Catheter Cardiovasc Interv (2009) 1.56
Increased basal nitric oxide release despite enhanced free radical production in hypertension. J Hypertens (2002) 1.54
Functional cross-talk between angiotensin II and epidermal growth factor receptors in NIH3T3 fibroblasts. J Hypertens (2002) 1.46
Left ventricular assist devices in chronic heart failure: more questions than answers? J Am Coll Cardiol (2013) 1.39
Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol (2013) 1.31
Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv (2012) 1.29
Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol (2013) 1.26
Cardiac stem cells: isolation, expansion and experimental use for myocardial regeneration. Nat Clin Pract Cardiovasc Med (2007) 1.25
Stem cells in the heart: what's the buzz all about? Part 2: Arrhythmic risks and clinical studies. Heart Rhythm (2008) 1.19
A chemical biology approach to myocardial regeneration. J Cardiovasc Transl Res (2011) 1.17
Early and long-term outcome in patients undergoing aortic root replacement with composite graft according to the Bentall's technique. Eur J Cardiothorac Surg (2002) 1.14
Cardiovascular influences of alpha1b-adrenergic receptor defect in mice. Circulation (2002) 1.13
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol (2011) 1.11
Stem cells in the heart: what's the buzz all about?--Part 1: preclinical considerations. Heart Rhythm (2008) 1.11
Traumatic aortic arch false aneurysm after blunt chest trauma in a motocross rider. J Cardiothorac Surg (2008) 1.10
Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med (2013) 1.08
Extracorporeal membrane oxygenation (ECMO) in patients with H1N1 influenza infection: a systematic review and meta-analysis including 8 studies and 266 patients receiving ECMO. Crit Care (2013) 1.04
Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials (2011) 1.03
Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks--an MRI study. PLoS One (2011) 1.02
Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol (2012) 1.01
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application. J Cell Mol Med (2010) 1.00
Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis. Heart (2012) 0.99
Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era. Eur Heart J (2013) 0.98
Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng (2007) 0.97
Isolation and expansion of adult cardiac stem/progenitor cells in the form of cardiospheres from human cardiac biopsies and murine hearts. Methods Mol Biol (2012) 0.96
Natural history of malignant bone disease in gastric cancer: final results of a multicenter bone metastasis survey. PLoS One (2013) 0.95
Double papillary fibroelastoma of the aortic valve. Tex Heart Inst J (2004) 0.95
Primary gastric plasmacytoma and Helicobacter pylori infection. J Clin Oncol (2008) 0.95
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer. Int J Cancer (2014) 0.94
Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs. Biomaterials (2011) 0.94
Electrophysiological properties of mouse bone marrow c-kit+ cells co-cultured onto neonatal cardiac myocytes. Cardiovasc Res (2005) 0.94
Resistin impairs insulin-evoked vasodilation. Diabetes (2007) 0.94
Coronary artery-left atrial fistula: displayed by 64-slice computed tomography. Tex Heart Inst J (2011) 0.90
Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica (2002) 0.90
A modified technique for repair of the anomalous origin of the right pulmonary artery from the ascending aorta. Eur J Cardiothorac Surg (2002) 0.89
Residual dissection of the brachiocephalic arteries: significance, management, and long-term outcome. J Thorac Cardiovasc Surg (2004) 0.89
TGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies. Stem Cells Dev (2012) 0.89
In situ retrocaval skeletonized right internal thoracic artery anastomosed to the circumflex system via transverse sinus: technical aspects and postoperative outcome. J Thorac Cardiovasc Surg (2003) 0.89
Cardiac cell therapy: the next (re)generation. Stem Cell Rev (2011) 0.88
Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. J Cell Mol Med (2011) 0.88
TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J (2002) 0.88
Pressure distension stimulates the expression of endothelial adhesion molecules in the human saphenous vein graft. Ann Thorac Surg (2003) 0.88
From ontogenesis to regeneration: learning how to instruct adult cardiac progenitor cells. Prog Mol Biol Transl Sci (2012) 0.87